annb0t
Top 20
Melbourne, Victoria --News Direct-- Incannex Healthcare Ltd
Incannex Healthcare Ltd (ASX:IHL NASDAQ:IXHL) CEO and MD Joel Latham sits down with Proactive to talk about the development and manufacturing deal it has struck with pharma giant Catalent to produce its own psilocybin drug. The product would initially be deployed in IHLâs clinical development program for generalised anxiety disorder, but there are plans down the track for its commercial use or supply as a cGMP pharmaceutical-grade...
>>> Read more: Incannex to work with Catalent to produce psilocybin for clinical and potentially commercial use
Incannex Healthcare Ltd (ASX:IHL NASDAQ:IXHL) CEO and MD Joel Latham sits down with Proactive to talk about the development and manufacturing deal it has struck with pharma giant Catalent to produce its own psilocybin drug. The product would initially be deployed in IHLâs clinical development program for generalised anxiety disorder, but there are plans down the track for its commercial use or supply as a cGMP pharmaceutical-grade...
>>> Read more: Incannex to work with Catalent to produce psilocybin for clinical and potentially commercial use
